glp 1 and substance use disorder GLP-1 receptor agonists disorders: new large-scale evidence from the BMJ A cohort study published in the BMJ this week (Cai, Choi, Xie, Al-Aly, 2026) examined over 600,000 US veterans glp-1 fatty liver toxicity BLOG Flavor:Blu Raz

glp 1 and substance use disorder GLP-1 receptor agonists disorders: new large-scale evidence from the BMJ A cohort study published in the BMJ this week (Cai, Choi, Xie, Al-Aly, 2026) examined over 600,000 US veterans glp-1 fatty liver toxicity BLOG Flavor:Blu Raz

glp-1 fatty liver toxicity The future of incretins in the treatment of obesity and non-alcoholic liver disease Hepatokines and MASLD: The GLP1-Ras-FGF21-Fetuin-A –

Neuropsychiatric reactions including suicidal thoughts have been reported with GLP analogs, although barely exceeding placebo and unlikely to warrant clinical concern (O'Neil et al, 2017)

BLOG

Flavor:Blu Raz

doi: 10.1186/s13098-017-0289-y